News

Peregrine is following the lead of many pharmaceutical companies including Pfizer, GlaxoSmithKline, Roche and Eli Lilly that have recently been conducting major clinical trials in India, taking advantage

Avastin will be used to specifically target non-small cell lung cancer, the most common type of lung cancer. The approval is based on a phase III study that

In a preliminary assessment of the application, the EMEA reviewers indicated that additional clinical data would be needed prior to potential approval. The company has said that based

“Based on the results we have generated to-date, MBP8298 appears to have the potential to fundamentally alter the course of this devastating disease,” said Kevin Giese, president and

Gene Logic's drug repositioning program seeks to find alternative development paths for drug candidates with good safety records. The program offers pharmaceutical partners a new approach to help

Oral TLF is currently in phase II clinical development for RCC. Talactoferrin Alfa is a unique recombinant form of human lactoferrin, known as an immunomodulatory protein. “Metastatic RCC

Clinical trials to date have demonstrated that treatment with Galvus results in sustained reductions in blood sugar levels, leading to improved glucose control. The most common side effects

The submission is based on safety and efficacy studies that evaluated bifeprunox for the treatment of schizophrenia. Patients were evaluated with acute exacerbations for six weeks, and stable

COPD, or chronic obstructive pulmonary disease, is a complex lung disease that results in a progressive decline in lung function that is ultimately debilitating and life-threatening. Results of